2. Academic Validation
  3. BODIPY Conjugates as Functional Compounds for Medical Diagnostics and Treatment

BODIPY Conjugates as Functional Compounds for Medical Diagnostics and Treatment

  • Molecules. 2022 Feb 18;27(4):1396. doi: 10.3390/molecules27041396.
Elena Antina 1,  Natalia Bumagina 1,  Yuriy Marfin 2,  Galina Guseva 1,  Liliya Nikitina 3 4,  Dmitry Sbytov 2,  Felix Telegin 2
Affiliations

Affiliations

  • 1 G.A. Krestov Institute of Solution Chemistry of Russian Academy of Sciences, 1 Akademicheskaya St., 153045 Ivanovo, Russia.
  • 2 Inorganic Chemistry Department, Ivanovo State University of Chemistry and Technology, 7 Sheremetevskiy Ave., 153000 Ivanovo, Russia.
  • 3 Department of General and Organic Chemistry, Kazan State Medical University, 49 Butlerova St., 420012 Kazan, Russia.
  • 4 Biologically Active Terpenoids Laboratory, Kazan Federal University, 18 Kremlyovskaya St., 420008 Kazan, Russia.
PMID: 35209191 DOI: 10.3390/molecules27041396
Abstract

Fluorescent dyes absorbing and emitting in the visible and near-IR regions are promising for the development of fluorescent probes for labeling and bio-visualization of body cells. The ability to absorb and emit in the long-wavelength region increases the efficiency of recording the spectral signals of the probes due to the higher permeability of the skin layers. Compared to Other fluorescent dyes, BODIPYs are attractive due to their excellent photophysical properties-narrow absorption and emission, intense fluorescence, simple signal modulation for the practical applications. As part of conjugates with biomolecules, BODIPY could act as a biomarker, but as therapeutic agent, which allows solving several problems at once-labeling or bioimaging and treatment based on the suppression of pathogenic microflora and Cancer cells, which provides a huge potential for practical application of BODIPY conjugates in medicine. The review is devoted to the discussion of the recent, promising directions of BODIPY application in the field of conjugation with biomolecules. The first direction is associated with the development of BODIPY conjugates with drugs, including compounds of platinum, paclitaxel, chlorambucil, isoxazole, capsaicin, etc. The second direction is devoted to the labeling of Vitamins, Hormones, lipids, and Other biomolecules to control the processes of their transport, localization in target cells, and metabolism. Within the framework of the third direction, the problem of obtaining functional optically active Materials by conjugating BODIPY with Other colored and fluorescent particles, in particular, phthalocyanines, is being solved.

Keywords

BODIPY; biomarker; conjugate; drug delivery; fluorescent label; luminophore.

Figures
Products